Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16+
SponsorCentre Hospitalier Universitaire de la Guadeloupe

About this trial

Dermatomyositis is a rare chronic autoimmune and inflammatory disease that affects the skin and striated muscles. Its prognosis is linked to visceral involvement (lungs, heart, and oropharyngeal region) and to the possible presence of associated cancer. The implementation of the research will allow identification of incident cases of dermatomyositis in Guadeloupe and the characterization of the disease in the overseas population, in the absence of data in the literature.

Eligibility criteria

Qualifiers

Patient with a diagnosis of dermatomyositis according to the 2003 ENMC criteria

Patient with parents or grandparents originating from the Caribbean arc

Patient aged 16 years or older

Patient residing in Guadeloupe

Disqualifiers

Patient who started treatment with intravenous immunoglobulins, corticosteroids, or immunosuppressants within the month prior to the diagnosis of dermatomyositis

Patient under legal protection (guardianship or trusteeship) or deprived of liberty

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

10 Participants
are grouped into 1 trial group